The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Lustral 100 mg film-coated tablets

100 milligram(s) Film-coated tablet

PCO Manufacturing Ltd.PPA0465/062/002

Main Information

Trade NameLustral 100 mg film-coated tablets
Active SubstancesSertraline hydrochloride
Strength100 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/062/002

Group Information

ATC CodeN06AB Selective serotonin reuptake inhibitors
N06AB06 sertraline

Status

Authorised/WithdrawnAuthorised
Licence Issued07/09/2001
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0064-024-003
Interchangeable List DocumentPDF of Interchangeable List
« Back